Guidance in brief: Prevention and control of infectious diseases among people who inject drugs - 2023 update
This guidance in brief complements the joint guidance, ‘Prevention and control of infectious diseases among people who inject drugs - 2023 update’.
It is available in all EU/EEA languages and provides an overview of the 2023 guidance developed by ECDC and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The full guidance aims to support policy-makers and public health/social programme planners by strengthening the evidence base for developing national strategies, policies, and programmes for preventing and controlling infections and infectious diseases among people who inject drugs.
Download
Read the full guidance
Guidance
Prevention and control of infectious diseases among people who inject drugs - 2023 update
This document is an update of the joint guidance that was published in 2011 by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
Models of good practice
Guidance
Models of good practice for community-based testing, linkage to care and adherence to treatment for hepatitis B and C, HIV, and tuberculosis and for health promotion interventions to prevent infections among people who inject drugs
The purpose of this collection is to identify practice-based evidence for interventions with a documented impact implemented in real-life settings.
